Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-13
2011-10-18
Morris, Patricia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S115000
Reexamination Certificate
active
08039481
ABSTRACT:
The present invention includes novel derivatives of bicyclic tetrahydrofuran imino acids of formula I,processes for their preparation, and uses thereof as medicaments. The compounds are suitable for use in the therapy and prophylaxis of diseases which are associated with an increased matrix metalloproteinase activity.
REFERENCES:
patent: 5866587 (1999-02-01), de Nanteuil et al.
patent: 6207672 (2001-03-01), Thorwart
patent: 6339092 (2002-01-01), de Nanteuil et al.
patent: 6573277 (2003-06-01), Thorwart
patent: 6770647 (2004-08-01), Sheppeck et al.
patent: 6815440 (2004-11-01), Thorwart
patent: 7205315 (2007-04-01), Schudok
patent: 2002/0137744 (2002-09-01), de Nanteuil et al.
patent: 2007/0155778 (2007-07-01), Schudok
patent: WO 99/06410 (1999-02-01), None
patent: 03/016248 (2003-02-01), None
patent: 2005/030728 (2005-04-01), None
patent: 2006/002764 (2006-01-01), None
Hofmeister Armin
Matter Hans
Schudok Manfred
Bolcsak James W.
Morris Patricia
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Tetrahydrofuran derivatives for use as inhibitors of matrix... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrofuran derivatives for use as inhibitors of matrix..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrofuran derivatives for use as inhibitors of matrix... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4276789